Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
SGLT2 inhibitors reduce dementia, Parkinson’s disease risk: study
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk for dementia and Parkinson’s disease, a new study finds.
Some Diabetes Drugs May Protect Against Dementia and Parkinson's
Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 diabetes.
Some diabetes meds might lower risk of dementia, Parkinson's
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
Type 2 drugs could lower dementia, Parkinson's disease risk
Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk of dementia, overall, and of Alzheimer's disease and Parkinson's, in particular.
These Diabetes Drugs Could Help Lower Your Risk of Dementia, Parkinson’s
According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or SGLT2 inhibitors, stop the kidneys from reabsorbing too much blood glucose to improve blood sugar levels.
Some diabetes medications linked to lower dementia, Parkinson's disease risk
Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By encouraging the kidneys to eliminate sugar from the body through urine, they reduce blood sugar.
SGLT2 inhibitors tied to lower risk of dementia, Parkinson’s disease, suggests study
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson’s disease, according to a study published in the September 18, 2024, online issue of Neurology®,
Diabetes Medications May Lower Risk of Dementia and Parkinson's Disease
A recent study suggests that a class of diabetes medications could be linked to a reduced risk of developing dementia an..|News Track
Some diabetes drugs tied to lower risk of dementia, Parkinson's disease
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology.
TCTMD
5h
Yes, Clinical Inertia IS the Leading Cause of GDMT Underuse in HFrEF
When surveyed, many physicians said the belief that patients had adequate symptom control was why they didn’t add more meds.
Medscape
8d
SGLT2 Inhibitor Reduces Risk for Neurodegenerative Diseases in T2D
"This was the largest nationwide population-based longitudinal cohort study to investigate the association between the use of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Secret Service admits failure
Kentucky judge fatally shot
$230 million crypto theft
Boy kills bear, saves father
Russia threatens retaliation
FCC chair denies Trump call
Secret Service probing post
Body found in SUV
Families lose appeal
Feds subpoena Schaeffer
Hiker injured in bear attack
1st rabies outbreak in seals
Hand count approved in GA
Bill to boost security OK'd
Hold campaign event in MI
Top Hezbollah leader killed?
Baby powder recalled
In-person voting begins
Sues pharmacy middlemen
144K+ Mavericks recalled
Raises settlement offer
MS sheriff's office probe
Recalling 449K+ vehicles
Collapse hazard recall
PGA welcomes LIV players
Vows to remain in race
Stein's ballot bid rejected
Disney to stop using Slack
Brazil threatens daily fines
$3B for battery projects
Related topics
Parkinson's disease
Diabetes
Feedback